These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4976271)

  • 21. Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell-free, chemical aerosol typhoid vaccine.
    Hejfec LB; Levina LA; Salmin LB; Antonova AA; Segal LS; Kuzminova ML; Slavina KM; Vasileva AV
    Dev Biol Stand; 1976; 33():93-7. PubMed ID: 821803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Typhoid and paratyphoid fever in Swedish travellers abroad--why do we vaccinate].
    Grillner L; Iwarson S
    Lakartidningen; 1974 Nov; 71(48):4931-2. PubMed ID: 4218289
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current aspects of anti-typhoid-paratyphoid vaccination with inactivated vaccines].
    Dimache G
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(5):385-94. PubMed ID: 4630431
    [No Abstract]   [Full Text] [Related]  

  • 24. [Typhoid and paratyphoid fevers 1982].
    Gonera E
    Przegl Epidemiol; 1984; 38(2):139-43. PubMed ID: 6438699
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
    Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
    Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of various interventions during a typhoid epidemic. Results of a simulation study.
    Lange HJ; Ulm K; Raettig H; Huber HC
    Infection; 1983; 11(2):97-103. PubMed ID: 6408009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problem of chronic typhoid and paratyphoid carriers from the sociological and epidemiologic viewpoint].
    Fiedler K
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1230-4. PubMed ID: 4994103
    [No Abstract]   [Full Text] [Related]  

  • 29. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas.
    Whitaker JA; Franco-Paredes C; del Rio C; Edupuganti S
    J Travel Med; 2009; 16(1):46-52. PubMed ID: 19192128
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of effectivity of oral killed typhoid and paratyphoid b vaccines and aerosol chemical thyphoid vaccine in controlled field trials.
    Hejfets LB; Levina LA; Salmin LV; Antonova AA; Segal LS; Kuzminova ML; Slavina KM; Vasileva AV
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):292-9. PubMed ID: 827582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Typhoid and paratyphoid immunization.
    Walker JH
    Practitioner; 1971 Apr; 206(234):478-82. PubMed ID: 4995968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidemiological and etiological characteristics of typhoid and paratyphoid fever in Ningbo during 1988 - 2007].
    Xu GZ; Xu JY; Zhou AM; Jin CG; Mao GH; Shi YZ; Dong HJ; Yang YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):252-6. PubMed ID: 19642380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Distribution and constancy of markers of lysotypes of Salmonella typhi and Salmonella paratyphi B in carriers].
    Kopplow E; Brandis H; Kneip H
    Arch Hyg Bakteriol; 1968 Aug; 152(4):372-8. PubMed ID: 4974903
    [No Abstract]   [Full Text] [Related]  

  • 34. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 35. [Typhoid and paratyphoid fevers in childhood. Apropos of 210 cases].
    de Juan Martín F; Pérez Gascón M; Martín Espíldora N
    An Esp Pediatr; 1986 Sep; 25(3):170-6. PubMed ID: 3098149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic importance of various methods of determining infectious O-antigenemia in patients with typhoid and paratyphoid fevers A and B].
    Cherkasov VL; Rubtsov IV; Erovichenkov AA; Kulakov VN; Tregub AV
    Ter Arkh; 1988; 60(11):35-8. PubMed ID: 2467391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The experimental foundation underlying several problems in the enteral method of vaccination. IV. The possibility of using antigen complexes from paratyphoid A bacteria as components of enteral vaccines].
    Mironova MV; Khatuntseva NV; Riapolova RG
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):44-7. PubMed ID: 4207096
    [No Abstract]   [Full Text] [Related]  

  • 38. [Typhoid and paratyphoid fevers in the province of Talca, Chile].
    Palomo I; Valdés E; León M; Herrera F; Ramos L; Rojas A; Pino M
    Rev Med Chil; 1988 Feb; 116(2):180-3. PubMed ID: 3148182
    [No Abstract]   [Full Text] [Related]  

  • 39. [The value of typhoid-paratyphoid vaccination; a recent epidemic in the military force].
    RENDU R
    Concours Med; 1954 Dec; 76(50):4643-8. PubMed ID: 13231442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of specific vaccination of monkeys against paratyphoid disease. II].
    Gekker VD; Stepanova LK; Stasilevich ZK; Ivanov MT
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jan; 44(1):38-42. PubMed ID: 4972897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.